Aisling Capital
General contacts
Investor type
PE / VC
Founded
2000
AUM
$1 800 M
Location
New York, New York, United States
Investor profile last updated: 24 July, 2025
Profile
Aisling Capital believes the next decade will be marked by a revolution in healthcare driven by new therapeutics generated by biotechnology. The completion of the human genome has given scientists new insights into the causes of human disease. These insights, combined with the past 20 years of developments in the biotechnology industry, are leading to rapid expansion of novel approaches toward the diagnosis, prevention, and treatment of life-threatening illnesses. These advances have led to an ever-increasing demand for capital to complete the development and commercialization of new therapeutics. Our goal is to support the leading global healthcare companies that are building on these technical and medical breakthroughs to commercialize new healthcare products.
Industry
Aisling Capital Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Aisling Capital IV
|
Venture Capital (VC)
|
Healthcare Services
Medical Devices
Life Sciences
|
Seed
Series A
|
North America
|
$5-10 m
|
$280 M
|
November 2017
|
|
Aisling Capital Fund V
|
Venture Capital (VC)
|
Healthcare Services
Medical Devices
Life Sciences
|
Seed
Series A
|
North America
|
$5-10 m
|
$144 M
|
June 2020
|
|
Aisling Capital I, L.P.
|
Venture Capital (VC)
|
Biotechnology
Healthcare Services
Medical Devices
Pharmaceuticals
Life Sciences
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$30 M
|
January 2013
|
|
Aisling Capital II
|
Venture Capital (VC)
|
Biotechnology
Healthcare Services
Medical Devices
Pharmaceuticals
Life Sciences
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$550 M
|
August 2015
|
Contacts
Name
Title
Email
Social Networks
Investment-team contacts for Aisling Capital — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
FAQs about Aisling Capital
Is Aisling Capital a venture capital or private equity firm?
Aisling Capital is a venture capital and private equity firm. It backs companies at Seed, Series B and Series A, writing tickets of $0-1 m.
Where is Aisling Capital located?
Aisling Capital is located in New York, New York, United States.
When was Aisling Capital founded?
Aisling Capital was founded in 2000.
What sectors and industries does Aisling Capital invest in?
Aisling Capital invests in companies and startups in Biotechnology, Fashion/Beauty, Financial Services, Fintech, Food and Beverage, Foodtech, Healthcare Services, Media and Entertainment, Robotics, Technology, Life Sciences, Energy, LegalTech, HealthTech, Pharmaceuticals, Medical Devices.
What is Aisling Capital geographical focus of investments?
Aisling Capital invests in companies and startups in North America, Europe.
At what stages of companies and startups does Aisling Capital typically invest in?
Aisling Capital invests in companies and startups at Seed, Series B, Series A.
What is the usual amount of Aisling Capital investment?
Aisling Capital usually invests $0-1 m on average.
What is the amount of assets of under management (AUM) for Aisling Capital?
Aisling Capital has around $1 800m assets under management.
When was Aisling Capital last fund created?
Aisling Capital last fund was created/launched in 2020-06-26
What are the contacts of Aisling Capital?
Aisling Capital can be reached through its website aislingcapital.com, its LinkedIn page and its X account. Its general enquiries address is info@aislingcapital.com. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Aisling Capital — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Can I access Aisling Capital data via API or MCP?
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Aisling Capital directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
When was the Aisling Capital profile last updated?
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 24 July, 2025. Something out of date here? Report it — we re-run that firm within 48h and get back to you.